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Abstract:
A four-month-old English bulldog was anaesthetised for investigation and 
management of chronic urinary incontinence. In the post-anaesthetic 
period the patient developed respiratory distress, with marked cough 
and increased inspiratory effort. Diagnostic imaging suggested 
pulmonary oedema. After excluding all other causes of cardiogenic and 
non-cardiogenic pulmonary oedema it was indicated that the patient 
developed post-anaesthetic negative pressure pulmonary oedema due to 
tracheal intubation with an oversized endotracheal tube leading to 
laryngeal swelling and obstruction. The animal was treated with oxygen 
supplementation, corticosteroids and β-2 adrenergic receptor agonists. 
The patient recovered from the event and was discharged from the 
hospital after forty-eight hours. This article discusses this case in further 
detail including other management options of negative pressure 
pulmonary oedema. This is the first case report focused on the 
pathophysiology, critical care and management of post-anaesthetic 
negative pressure pulmonary oedema in a dog.
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TITLE OF CASE Do not include “a case report”
POSTOBSTRUCTIVE NEGATIVE PRESSURE PULMONARY OEDEMA IN A DOG
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A four-month-old English bulldog was anaesthetised for investigation and management of 
chronic urinary incontinence. In the post-anaesthetic period the patient developed 
respiratory distress, with marked cough and increased inspiratory effort. Diagnostic imaging 
suggested pulmonary oedema. After excluding all other causes of cardiogenic and non-
cardiogenic pulmonary oedema it was hypothesised that the patient developed 
postanaesthetic negative pressure pulmonary oedema, suspected to have been exacerbated by 
tracheal intubation with an oversized endotracheal tube leading to laryngeal swelling and 
obstruction. The animal was treated with oxygen supplementation, corticosteroids and β-2 
adrenergic receptor agonists. The patient recovered from the event and was discharged from 
the hospital after forty-eight hours. This article discusses in further details other management 
options of negative pressure pulmonary oedema. This is the first case report discussing the 
pathophysiology, critical care and management of post-anaesthetic negative pressure 
pulmonary oedema in a dog.
BACKGROUND Why you think this case is important – why did you write it up?
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Pulmonary oedema is defined as an abnormal accumulation of fluid in the extravascular tissues and 
spaces of the lung that occurs when the lymphatic circulation is unable to drain the excessive fluid 
present in the extravascular space 1.
Post-obstructive pulmonary oedema can be subdivided into two types: Type 1 which is associated 
with an increase in inspiratory effort due to an acute upper airway obstruction (UAO) and type 2 
which results from a the relief of a chronic partial UAO (e.g. after laryngeal mass resection) 2. Post-
obstructive pulmonary oedema type 1 is also known as negative pressure pulmonary oedema 
(NPPO) and has been highlighted as a potential complication in the post-anaesthetic period in 
people and horses3,4.  Multiple causes have been attributed to the development of NPPO: 
brachycephalic obstructive airway syndrome (BOAS), strangulation, choking, near drowning, 
airway collapse, laryngeal mass, laryngeal paralysis, endotracheal tube (ETT) obstruction, 
laryngospasm and partial occlusion of the upper airway tract with a foreign body or other mass 2,5. 
The pathophysiologic mechanism behind NPPO was primarily described in the 1940s 6 and it is  
now accepted that this is a multifactorial process involving negative pressures and hypoxia2. 
Physiologically the UAO creates a large negative transpulmonary and interpleural pressure gradient 
favouring movement of fluid from the capillaries through the alveolar capillary barrier into the 
extravascular space 3. This increase in hydrostatic pressures and oedema formation in the lungs 2,7, 
contributes to the  leading to lung tissue oedema and the overall translocation of fluid from the 
capillaries into the alveolar spaces. 
In the veterinary literature few reports have been published discussing this event. In 1927, a 
research article reporting the response to respiratory resistance in dogs found that a partial fixed 
obstruction during a prolonged inspiratory phase resulted in lesions compatible with pulmonary 
oedema at post-mortem examination 8. In 1989 and 1995, two case series described the 
development of pulmonary oedema in conscious dogs due to UAO resulting from laryngeal 
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paralysis, laryngeal  oedema or obstructive airway masses 9,10. Another case series was recently 
published describing the radiographic appearance of 23 cases with presumed post-obstructive 
pulmonary oedema in conscious dogs 5.
To the authors knowledge this is the first case report in the veterinary literature describing the 
pathophysiology, critical care and management of post-anaesthetic NPPO in a dog.
CASE PRESENTATION Presenting features, clinical and environmental history
A four-month-old, 11.6 kg, body condition score 6/9 11, female English Bulldog was presented for 
investigation and management of chronic urinary incontinence of one-month duration. At 
presentation the patient was bright and alert. Clinical examination revealed a recessed vulva and  
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urine-stained fur in the peri-vulvar area. Thoracic auscultati n was unremarkable, respiratory rate 
was 32 rpm and no obvious BOAS was detected. Cardiac auscultation was unremarkable (no 
murmurs detected) and the heart rate was 140 bpm with regular rhythm. Temperature recorded was 
38ºC. Blood haematology and serum biochemistry were unremarkable.  An American Society of 
Anaesthesiology (ASA) physical status classification of 2 was assigned to the dog 12. A Computed 
Tomography (CT) scan of the thorax and abdomen, under sedation, was scheduled for the same 
day. The patient was premedicated with 0.01mg/kg medetomidine (Medetor, Virbac) and 0.2mg/kg 
butorphanol (Dolorex, MSD Animal Health) by intramuscular injection. A 22 gauge intravenous 
cannula was placed aseptically in the left cephalic vein.  Oxygen was supplemented via face mask 
throughout the sedation period at a flow rate of 4L/min. Fluid therapy was initiated, before CT 
contrast was administered, with Hartmann’s Solution (Aqupharm 11, Animacare) at a rate of 
4mL/kg/hr. Pulse oximetry, non-invasive oscillometric blood pressure measurement, pulse rate and 
respiratory rate were monitored using a multiparameter monitor (Datex-Ohmeda S/5, GE 
Healthcare). 
CT examination of the abdomen following intravenous injection of contrast medium revealed 
dilation of the urethra with absence of normal vesiculourethral junction and mild dilation of the left 
ureter. 
A retrograde vaginourethrogram was immediately performed under general anaesthesia, 
immediately  after the CT scan. Propofol 2mg/kg (PropoFlo Plus, Zoetis) was administered 
intravenously. The trachea was intubated using a cuffed (high volume, low pressure) 8 mm inner 
diameter polyvinyl chloride (PVC) ETT. No difficulties were encountered during tracheal 
intubation although the ETT was found to be close-fitting as no cuff inflation was required when 
leak testing the system. General anaesthesia was maintained with sevoflurane (SevoFlo, Zoetis) 
vaporised in 100 per cent oxygen. Anaesthetic monitoring included electrocardiography, pulse 
oximetry, capnography and noninvasive oscillometric blood pressure measurement using a 
multiparameter monitor (DatexOhmeda S/5, GE Healthcare).  The trachea was extubated as soon 
as the patient swallowed, no complications were detected at that time, and no fluid or foam were 
visualised in the ETT. There were no breathing difficulties or signs of gastroesophageal reflux 
(GOR) detected after extubation. The patient was hypothermic in the recovery period (35.9ºC). In 
order to treat the hypothermia active warming was initiated with an active warming device (Hot 
Dog Patient Warming; Augustine Surgical Inc) and further temperature measurements were 
performed until the hypothermia resolved three hours after extubation. The patient was kept on 
intravenous fluid therapy for fifteen hours at a rate of 4ml/kg/hr, using a fluid pump, in order to 
avoid CT contrast induced nephropathy 13. Fluid therapy guidelines suggest maintenance fluid rates 
between 2-6 ml/kg/hr in healthy dogs 14. Well-hydrated patients with normal renal and heart 
function are generally able to regulate and excrete this fluid volumes. Although unlikely, this fluid 
therapy 
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regime may have predisposed the patient to volume overload.
The animal was hospitalised overnight and was examined every four hours.  The patient was 
considered clinically normal for the last time at 4am. At 8 am, fourteen hours after general 
anaesthesia, clinical examination of the patient revealed coughing, respiratory distress with a 
marked increase in inspiratory effort and a respiratory rate of 40 rpm. During thoracic auscultation 
increased upper respiratory sounds and wheezes were heard and. nNo crackles were noticed. On 
cardiac auscultation, no heart murmur was heard, the patient had a regular heart rhythm, the heart 
rate was 124 bpm, mucous membranes were pink and moist, and the capillary refill time was one 
second. Rectal temperature measured was 38,7ºC. Urgent thoracic radiographs were performed to 
establish the origin of the sudden onset of respiratory distress. The possibility of regurgitation 
followed by aspiration and subsequent pneumonia was suspected. 
INVESTIGATIONS If relevant
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In order to perform radiographs, the patient was sedated with 0.001mg/kg medetomidine (Medetor, 
Virbac) and 0.2mg/kg butorphanol (Dolorex, MSD Animal Health) intravenously. Dorsoventral 
and lateral inspiratory thoracic radiographs were obtained (Fig.1).  A generalised increase in soft 
tissue and ground glass opacities of the pulmonary parenchyma was identified, associated with 
multiple air bronchograms (unstructured interstitial and alveolar lung patterns). The pulmonary 
lesions were more severe in the perihilar region and reduced in severity towards the periphery. The 
border of the cardiac silhouette was partially effaced by the neighbouring lung changes, but the 
cardiac silhouette was not enlarged. Retrospectively, the CT of the caudal thorax earlier performed 
revealed no abnormalities in the caudal two thirds of the lungs. Tracheal inner diameter measured 
8.92mm and thoracic inlet measurement 6.67cm.  The tracheal : thoracic inlet ratio was within 
normal limits for a English Bulldog (0.134) 15,16.
Due to the more severe pulmonary lesions in the perihilar region suggesting the possibility of 
cardiogenic pulmonary oedema, a single dose of furosemide at 2mg/kg was administered 
intravenously promptly and an echocardiography was performed. Neither left nor right atrial 
enlargement was identified and systolic function appeared normal. There were no valvular 
regurgitations and no evidence of increased filling pressures detected; therefore, cardiogenic cause 
of pulmonary oedema was discarded.
The pharynx and the larynx were visually examined using  a laryngoscope with a light source 
withwhile the animal was profoundly sedated. The larynx was found to be grossly inflamed with 
erythema and swelling of the area. No mass, foreign body, laryngeal paralysis or other source of 
UAO was 
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DIFFERENTIAL DIAGNOSIS If relevant
From the history, presentation and radiographic findings a non-cardiogenic pulmonary oedema was 
highly suspected. Alternative differential diagnoses included idiopathic interstitial pneumonia, 
neoplastic infiltration or non-witnessed aspiration pneumonia.
A presumptive diagnosis of post-anaesthetic NPPO was made.
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TREATMENT If relevant 
Page 13 of 33 Veterinary Record Case Reports
1
2
3
4
5
6
7
8
54
55
56
57
58
59
60
Revised August 2017
The dog was transferred to the intensive care unit. The patient showed laboured breathing and a 
significant stertor could be heard. Positioning the patient with the neck extended significantly 
improved the her level of comfort. A continuous rate infusion of butorphanol  (Dolorex; MSD 
Animal Health) at 0.2mg/kg/hr was started to provide sedation, analgesia and antitussive therapy 
with minimal respiratory depression 17,18. Oxygen supplementation via nasal prongs was 
implemented at a flow rate of 1.5L min-1. Saturation of haemoglobin with oxygen was monitored 
using a portable pulse oximeter (Radical 7 Pulse Oximeter; Masimo). No episodes of patient’s 
desaturation were reported, pulse oximeteroxygen haemoglobin saturation values were always 
above 95% of saturation of haemoglobin with oxygen.
Salbutamol nebulization therapy (Ventolin: Glaxo Smith Klein) was initiated at a dose of 0.035 
mg/kg TID administered via metered dose inhalers over periods of 6 breaths using an aerosol 
chamber with a fitted face mask (AeroDawg; Truddel Medical International). 
Therapy with dexamethasone (0.2mg/kg IV SID) (Colvasone, Norbook); omeprazole (1mg/kg IV 
BID) (Omeprazole; Star Pharmaceuticals Ltd.); and cefuroxime (20mg/kg IV TID) (Zinacef; 
GlaxoSmithKlein) was initiated due to the possibility of regurgitation followed by aspiration and 
subsequent pneumonia as a potential differential diagnosis at the time. 
OUTCOME AND FOLLOW-UP  
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The animal responded well to treatment. Sixteen hours after the initial clinical signs, the patient 
was bright and alert. Respiratory rate decreased (20 rpm), no cough or increased inspiratory effort 
was detected. All medications were discontinued 36 hours after recognition of the clinical signs. 
The animal was discharged from the hospital 48 hours after this event. Unfortunately, no follow up 
imaging was performed.
Six months after discharge the animal has fully recovered from this episode with no complications 
arising from the NPPO. 
DISCUSSION Include a very brief review of similar published cases 
DIFFERENTIAL DIAGNOSIS
The possibility of aspiration and secondary pneumonia was initially suspected before diagnostic 
imaging was performed.  In anaesthetised dogs, gastric oesophageal reflux (GOR) has a high 
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incidence, which ranges from 16 per cent19 to 55 per cent20. A clinical trial showed a higher 
incidence of GOR (60 per cent vs 40 per cent) when comparing anaesthetised brachycephalic and 
non-brachycephalic dogs, although this the difference was not statistically significant21.  This is, in 
part, related to the high negative intrathoracic pressures generated to overcome the upper 
respiratory tract obstruction 22–24. GOR is associated with an increased risk of aspiration and 
secondary pneumonia 
22,24.
In this casethe case reported here and with hindsight, we can excludeexcluded  the possibility of 
aspiration pneumonia as the cause of the pulmonary oedema due to the rapid resolution of the 
clinical signs. Two studies reflected on the duration of hospitalization hospitalisation for dogs with 
aspiration pneumonia and resolution of clinical signs. Results showed in these studies ranged from 
3 to 5 days of hospitalization in the intensive care unit for dogs recovering from aspiration 
pneumonia 25,26. 
In terms of radiographyMoreover, there are different radiographic appearances when comparing 
NPPO to aspiration pneumonia. In aspiration pneumonia the most gravity dependent areas are the 
most frequently affected27. The positioning of the patient during aspiration may predict the location 
of pulmonary infiltrates. In sternal recumbency it is more likely that the right lung is affected, as 
the right mainstem bronchus is a more direct prolongation of the trachea than the left. In 
ventrodorsal positioning the caudal lung lobes seem to be more affected 28. A recent case series 
focused on the radiographic appearance of non-cardiogenic pulmonary oedema suggested that a 
dorsal distribution of the lung lesions seemed to be more often observed in NPPO than in other 
causes of non-cardiogenic pulmonary oedema, although, the authors could not give an explanation 
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In dogs with experimentally induced lung aspiration, radiographic signs were only seen 24 hours 
post aspiration and clinical signs of cough and respiratory distress were only present two days after 
the event 28. In this case, clinical signs and radiographic changes occurred between ten to fourteen 
hours after extubation, although aspiration before sedation cannot be excluded. Also, abnormal 
radiographic findings were mainly caudodorsally located which differs from cases of aspiration 
pneumonia.  
In human medicine, this post-anaesthetic complication NPPO has a variable onset of clinical signs, 
it maywhich may vary from few minutes to several hours (up to 24 hours) following extubation or 
relief of obstruction 2,29,30. Delayed onset of laryngeal oedema due to trauma has been reported as 
a complication of the surgical treatment of BOAS in dogs31. In one case series, four dogs developed 
laryngeal oedema post-surgery. The onset of clinical signs of upper airway obstruction, such as 
increased respiratory effort and cyanosis, were noted one, three, seven and ten hours after surgery. 
The authors mentioned that the laryngeal oedema could have resulted from surgery trauma or 
induced by the ETT31.
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Other causes of non-cardiogenic pulmonary oedema, such as direct lung injury (fire smoke 
exposure, toxin inhalation); neurogenic oedema (electrocution); systemic disease (neoplasia, 
uremic syndrome, pancreatitis); near drowning; blood transfusion; anaphylaxis5 were also 
discarded by clinical history, clinical examination and blood analysis. Neurogenic oedema due to 
seizures is difficult to completely exclude as the animal was not constantly monitored overnight 
and a seizure episode cannot be completely excluded. Although, to date, no history or clinical signs 
of neurologic disease have been reported in this patient, therefore the main causes of neurogenic 
pulmonary oedema were considered unlikely. 
CONTRIBUTION FACTORS FOR THE DEVELOPMENT OF NPPO
PATHOPHYSIOLOGY
It is believe that the animal described here suffered from type 1 post-obstructive pulmonary 
oedema, due to a suspected upper airway obstruction caused by gross swelling and erythema of the 
larynx. This may have been exacerbated from suspected trauma during tracheal intubation with an 
oversized ETT. A recent study in Beagles suggested that a suitably sized ETT for dogs should 
measure 70% of the internal tracheal diameter measured on thoracic radiography32. In this particular 
case, the measurement using the same method revealed 8.92mm internal tracheal diameter which 
corresponds to a 6.2mm ETT. An 8mm ETT was used to intubate the trachea of this patient, which 
could potentially explain the laryngeal swelling, erythema and secondary post extubation UAO.
BOAS
BOAS has an impact on the management of these patients during anaesthesia and recovery 22. 
BOAS is characterised by dynamic and/or static UAO33. These patients suffering from this 
syndrome are subjected to an increased resistance to inspiratory airflow which results in increased 
inspiratory effort and the generation of supraphysiologic negative thoracic and airway pressures 33. 
In severe cases of BOAS, UAO can result in NPPO 22. In our patient brachycephalic conformation 
may have played a role in aggravating the UAO.
SEDATION
This animal was sedated with a low dosage of medetomidine to safely perform the radiographs and 
the echocardiography. In cases of NPPO, α2-agonists must be used with caution. Profound sedation 
with this class of drugs induces recumbency, reduces pharyngeal muscle tone and may predispose 
to hypoventilation. All of these factors can theoretically worsen any UAO already present 22,34. On 
the other hand, sedation may be useful in controlling excessive panting associated with stress, 
reducing further airway swelling or collapse and decreasing oxygen consumption22.  This animal 
was sedated with a low dosage of medetomidine to safely perform the radiographs and the 
echocardiography. This patient was closely monitored for signs of UAO including increased 
stertor/stridor, increased inspiratory effort and exaggerated movement of the chest wall.  
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Elevating the patient’s head improved the audible stertor/stridor during sedation. Oxygen was 
supplemented via face mask and haemoglobin saturation with oxygen was monitored via pulse 
oximetry at all times during this process. If necessary antipamezole could have been administrated 
in this case, as this α2-antagonist counteracts the respiratory depression caused by the 
administration of α2-agonists 35,36. Butorphanol can be used to provide sedation, analgesia and 
antitussive therapy with minimal respiratory depression in cases of respiratory distress and was 
used successfully 17,18.
PAEDIATRIC PATIENT
The fact that this was a paediatric patient may have played a role in the development of pulmonary 
oedema in this case. Young animals have a smaller functional residual capacity, therefore they will 
quickly develop hypoxia in the event of an UAO 37,38. The rib cage of young animals is very 
compliant, resulting in less competent ventilation and greater work of breathing. This may 
predispose paediatric patients to hypoxia and ventilatory fatigue, which can be aggravated in the 
event of an UAO38. The larynx of puppies is delicate, and extreme care should be taken to intubate 
the trachea atraumatically 37. This patient was 4 months old and intubation of the trachea was 
performed with an oversized ETT which potentially caused the laryngeal oedema, which was 
theorised to be the cause of the UAO. Hypoxia may have developed quicker in this patient for the 
reasons described above. 
TREATMENT
The priorities in patients presenting NPPO are to relieve the UAO and correct the hypoxaemia. 
Supportive care should be implemented aiming to maintain a patent airway and ensuring ensure 
adequate oxygenation 2,39. Oxygen supplementation, continuous positive airway pressure (CPAP), 
intermittent positive pressure ventilation (IPPV) and positive end-expiratory pressure (PEEP) are 
methods used described to fulfil those goals. Other medications such as glucocorticoids and β2-
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OXYGEN SUPPLEMENTATION
Traditional oxygen therapy is most usually provided via a face mask, nasal prongs or oxygen cage, 
delivering dry, cold oxygen with FIO2 of 40 to 70% at flow rates of 50–150 mL/kg/min 40.  In a 
research project including twenty healthy dogs, the mean partial pressure of oxygen (PaO2) in 
arterial samples taken after face mask oxygen supplementation was 371.3 mmHg compared to the 
control group composed by dogs breathing room air (82.43 mmHg) 40. Passive oxygen 
administration via a nasal prongs was chosen in this case to provide oxygen to the patient. 
Unfortunately, no arterial blood gas analysis was performed; this could have provided more reliable 
information regarding the haemoglobin saturation with oxygen and PaO2.
CPAP
CPAP is a mode of ventilation used in spontaneously breathing subjects. This is used in humans 
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for the treatment of NPPO and sleep apnoea2,41 . The objective of CPAP is to maintain a positive 
pressure in the airways during inspiration and expiration. This The intrathoracic positive pressure 
at the end of expiration will improves alveolar ventilation and re-expand flooded alveoli, promoting 
the fluid to return to the interstitial space 42. Other benefits of CPAP include a reduction in preload 
due to an increase in intrathoracic pressure and a reduction in afterload, via an increase in 
pericardial pressure and reduction in transmural pressure 42. It also improves oxygenation, gas 
exchange, vital signs and reduces work of breathing  43,44. One of the advantages of CPAP delivery 
is that there is no need for tracheal intubation and mechanical ventilation. No CPAP delivering 
devices have has been specifically designed for veterinary patients. Two human interfaces for 
CPAP delivery have been studied in dogs, 45,46. In healthy sedated dogs, when comparing CPAP 
via face mask with traditional oxygen therapy delivered via regular face mask, CPAP increased 
PaO2 by 102 mmHg and was well tolerated by the patients 45. Some Ddisadvantages have been 
highlighted in a research project testing three methods of non-invasive CPAP delivery (custom-
made mask, conical face mask and helmet): significant leaks were found when CPAP was delivered 
to sedated dogs. There is a significant risk of rebreathing and hypoxaemia when CPAP was not 
maintained. The authors concluded that animals should always be supervised during administration 
of CPAP 47. In our patient this method of ventilation was not used because it was not available. at 
the time, Iin our opinion it would have been a valid option for treatment of this patient because it 
would maintain a patent airway, improved oxygenation and reduced the work of breathing. 
Nevertheless, the temperament of the animal could have limited the use of CPAP in this case.
IPPV
IPPV with PEEP has been used in veterinary medicine for treatment of non-cardiogenic pulmonary 
oedema 48. The application of PEEP counterbalances the hydrostatic forces leading to pulmonary 
oedema, redistributing the extravascular fluid from the alveoli into perivascular interstitium and 
maintaining airway patency 49. PEEP also improves gas exchange and recruits alveolar units. 
Application of PEEP up to 13 cmH2O improved alveolar gas exchange in experimentally induced 
canine pulmonary oedema 50,51. In this case IPPV and PEEP were not used because this would 
require endotracheal intubation which could have perpetuated the laryngeal inflammation already 
present. In human patients with NPPO, IPPV and PEEP are only implemented in severe cases of 
hypoxaemia, ventilation/perfusion mismatch and poor lung compliance2. IPPV and PEEP may 
present disadvantages when compared to other methods of ventilation such as CPAP. These 
included: an increased risk of morbidity and mortality;  the development of pneumonia, volutrauma 
and barotrauma; requirements for expensive and specialised equipment and staff; higher costs of 
patient management in an ICU setting 45,52.
FUROSEMIDE
In patients suffering from fluid overload, diuretics may play a part in the resolution of pulmonary 
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oedema, but in other cases their roleits indication remains uncertain 53,54. The reasoning behind 
using diuretics in these cases isDiuretics can be administered toi in an attempt to decrease the 
intravascular volume and alter Starling’s equation in favour of intra capillary filtration and oedema 
resolution 30. In our patient Furosemide was administered after radiographs confirmed pulmonary 
oedema. We had a concern that our patient may have been fluid overloaded, as she received fluid 
therapy at a rate of 4ml/kg/hr for a period of fifteen hours. The echocardiography discarded that 
possibility as well as cardiogenic pulmonary oedema. 
Therefore the use of furosemide could have been avoided in this particular case.
CORTICOSTEROIDS
Upper airway inflammation is associated with airway narrowing and obstruction. This increases 
airway resistance, may perpetuate inflammation and worsen coughing episodes. In the short 
termshort-term glucocorticoids may be useful in animals with BOAS with pharyngeal or laryngeal 
swelling55. Glucocorticoids wereDexamethasone was used in this our case after examination of the 
larynx, to decrease the inflammation detected in that area.
SALBUTAMOL
β2-agonists may be useful in lower airway disease in dogs55.  The use of β2-agonists is current 
practice in the treatment of NPPO in human medicine59In human medicine, aerosoliszed salbutamol 
was found to accelerate the resolution of pulmonary oedema, improve blood oxygenation, and 
stimulate cardiovascular function after lung lobe resection56.  β2-agonists could potentially increase 
the rate of alveolar fluid clearance through increased active cation transport, which may well 
accelerate the resolution of the clinical signs of pulmonary oedema57,58. The use of β2-agonists is 
current practice in the treatment of NPPO in human medicine59.Furthermore Interstitial oedema 
may induce narrowing of the bronchial lumen. This can be detected on thoracic auscultation as 
wheezing sounds57. In our case, clear wheezing was detected on thoracic auscultation; therefore, 
nebulisation bronchodilation with salbutamol was initiated.
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field
• Endotracheal intubation should be performed atraumatically with an appropriately sized ETT (in 
length and diameter). When intubating the trachea of a patient correct position of the patient, use 
of laryngoscope (which provides adequate light and visualization visualisation of the larynx) and 
appropriate depth of anaesthesia are extremely important to avoid complications.
• Delayed onset of laryngeal oedema resulting in NPPO is possible; . therefore animals should be 
closely monitored in the post-operative period.
• NPPO is a potential complication in the pre-anaesthetic period and can be treated with oxygen 
supplementation, corticosteroids and short-acting β2-agonists. 
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 Early recognition of the clinical signs and establishment of a prompt diagnosis is extremely important 
in the outcome of the case.
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A four-month-old English bulldog was anaesthetised for investigation and management of 
chronic urinary incontinence. In the post-anaesthetic period the patient developed 
respiratory distress, with marked cough and increased inspiratory effort. Diagnostic imaging 
suggested pulmonary oedema. After excluding all other causes of cardiogenic and 
non-cardiogenic pulmonary oedema it was hypothesised that the patient developed post-
anaesthetic negative pressure pulmonary oedema, suspected to have been exacerbated by 
tracheal intubation with an oversized endotracheal tube leading to laryngeal swelling and 
obstruction. The animal was treated with oxygen supplementation, corticosteroids and β-2 
adrenergic receptor agonists. The patient recovered from the event and was discharged from 
the hospital after forty-eight hours. This article discusses in further details other management 
options of negative pressure pulmonary oedema. This is the first case report discussing the 
pathophysiology, critical care and management of post-anaesthetic negative pressure 
pulmonary oedema in a dog.
BACKGROUND Why you think this case is important – why did you write it up?
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Pulmonary oedema is defined as an abnormal accumulation of fluid in the extravascular tissues and 
spaces of the lung that occurs when the lymphatic circulation is unable to drain the excessive 
fluid present in the extravascular space 1.
Post-obstructive pulmonary oedema can be subdivided into two types: Type 1 which is associated 
with an increase in inspiratory effort due to an acute upper airway obstruction (UAO) and type 2 
which results from a relief of a chronic partial UAO (e.g. after laryngeal mass resection) 2. 
Postobstructive pulmonary oedema type 1 is also known as negative pressure pulmonary oedema 
(NPPO) and has been highlighted as a potential complication in the post-anaesthetic period in 
people and horses3,4.  Multiple causes have been attributed to the development of NPPO: 
 
drowning, 
airway collapse, laryngeal mass, laryngeal paralysis, endotracheal tube (ETT) obstruction, 
laryngospasm and partial occlusion of the upper airway tract with a foreign body or other mass 2,5.
The pathophysiologic mechanism behind NPPO was primarily described in the 1940s 6 and it is 
 is a 
a large negative transpulmonary and interpleural pressure 
gradient favouring movement of fluid from the capillaries through the alveolar capillary barrier 
into the extravascular space 3. This increase in hydrostatic pressures and oedema formation in the 
lungs 2,7, contributes to the overall translocation of fluid from the capillaries into the alveolar 
spaces. 
In the veterinary literature few reports have been published discussing this event. In 1927, a 
research article reporting the response to respiratory resistance in dogs found that a partial fixed 
obstruction during a prolonged inspiratory phase resulted in lesions compatible with pulmonary 
oedema at post-mortem examination 8. In 1989 and 1995, two case series described the 
development of pulmonary oedema in conscious dogs due to UAO resulting from laryngeal 
paralysis, laryngeal  oedema or obstructive airway masses 9,10. Another case series was recently 
published describing the radiographic appearance of 23 cases with presumed post-obstructive 
pulmonary oedema in conscious dogs 5.
To the authors knowledge this is the first case report in the veterinary literature describing the 
brachycephalic obstructive airway syndrome (BOAS), strangulation, choking, near
now accepted that this
multifactorial process involving negative pressures and hypoxia2. 
Physiologically the UAO creates 
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pathophysiology, critical care and management of post-anaesthetic NPPO in a dog.
CASE PRESENTATION Presenting features, clinical and environmental history
A four-month-old, 11.6 kg, body condition score 6/9 11, female English Bulldog was presented for 
investigation and management of chronic urinary incontinence of one-month duration. At 
presentation the patient was bright and alert. Clinical examination revealed a recessed vulva and 
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urine-stained fur in the peri-vulvar area. Thoracic auscultation was unremarkable, respiratory rate  
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was 32 rpm and no obvious BOAS was detected. Cardiac auscultation was unremarkable (no 
murmurs detected) and the heart rate was 140 bpm with regular rhythm. Temperature recorded was 
38ºC. Blood haematology and serum biochemistry were unremarkable.  An American Society of 
Anaesthesiology (ASA) physical status classification of 2 was assigned to the dog 12. A Computed 
Tomography (CT) scan of the thorax and abdomen, under sedation, was scheduled for the same 
day. The patient was premedicated with 0.01mg/kg medetomidine (Medetor, Virbac) and 0.2mg/kg 
butorphanol (Dolorex, MSD Animal Health) by intramuscular injection. A 22 gauge intravenous 
cannula was placed aseptically in the left cephalic vein.  Oxygen was supplemented via face mask 
throughout the sedation period at a flow rate of 4L/min. Fluid therapy was initiated, before CT 
contrast was administered, with Hartmann’s Solution (Aqupharm 11, Animacare) at a rate of 
4mL/kg/hr. Pulse oximetry, non-invasive oscillometric blood pressure measurement, pulse rate and 
respiratory rate were monitored using a multiparameter monitor (Datex-Ohmeda S/5, GE 
Healthcare). 
CT examination of the abdomen following intravenous injection of contrast medium revealed 
dilation of the urethra with absence of normal vesiculourethral junction and mild dilation of the left 
ureter.            
A retrograde vaginourethrogram was immediately performed under general anaesthesia, after the 
CT scan. Propofol 2mg/kg (PropoFlo Plus, Zoetis) was administered intravenously. The trachea 
was intubated using a cuffed (high volume, low pressure) 8 mm inner diameter polyvinyl chloride 
PVC) ETT. No difficulties were encountered during tracheal intubation although the ETT was 
found to be close-fitting as no cuff inflation was required when leak testing the system. 
General anaesthesia was maintained with sevoflurane (SevoFlo, Zoetis) vaporised in 
100 per cent oxygen. Anaesthetic monitoring included electrocardiography, pulse oximetry, 
capnography and noninvasive oscillometric blood pressure measurement using a multiparameter 
monitor (DatexOhmeda S/5, GE Healthcare).  The trachea was extubated as soon as the patient 
swallowed, no complications were detected at that time, and no fluid or foam were visualised in 
the ETT. There were no breathing difficulties or signs of gastroesophageal reflux (GOR) detected 
after extubation. The patient was hypothermic in the recovery period (35.9ºC). In order to treat the 
hypothermia active warming was initiated with an active warming device (Hot Dog Patient 
Warming; Augustine Surgical Inc) and further temperature measurements were performed until the 
hypothermia resolved three hours after extubation The patient was kept on intravenous fluid therapy 
for fifteen hours at a rate of 4ml/kg/hr, using a fluid pump, in order to avoid CT contrast induced 
nephropathy 13. Fluid therapy guidelines suggest maintenance fluid rates between 2-6 ml/kg/hr in 
healthy dogs 14. Well-hydrated  are generally able to regulate and excrete this fluid volumes. 
Although unlikely, this fluid therapy 
(
patients with normal renal and heart function
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of 16 regime may have predisposed the patient to volume overload.
The animal was hospitalised overnight and was examined every four hours.  The patient was 
 at 
anaesthesia, clinical examination of the patient revealed
a
auscultation increased upper respiratory sounds and wheezes were heard and no crackles were 
noticed. On cardiac auscultation, no heart murmur was heard, the patient had a regular heart rhythm, 
the heart rate was 124 bpm, mucous membranes were pink and moist, and the capillary refill time 
was one second. Rectal temperature measured was 38,7ºC. Urgent thoracic radiographs were 
performed to establish the origin of the sudden onset of respiratory distress. The possibility of 
regurgitation followed by aspiration and subsequent pneumonia was suspected. 
considered clinically normal for the last time 4am. At
marked increase in inspiratory effort and 
 8 
 general 
 a 
 respiratory rate of 40 rpm. During thoracic 
am, fourteen hours after
coughing, respiratory distress with
INVESTIGATIONS If relevant
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In order to perform radiographs, the patient was sedated with 0.001mg/kg medetomidine (Medetor, 
Virbac) and 0.2mg/kg butorphanol (Dolorex, MSD Animal Health) intravenously. Dorsoventral 
and lateral inspiratory thoracic radiographs were obtained (Fig.1).  A generalised increase in soft 
tissue and ground glass opacities of the pulmonary parenchyma was identified, associated with 
multiple air bronchograms (unstructured interstitial and alveolar lung patterns). The pulmonary 
lesions were more severe in the perihilar region and reduced in severity towards the periphery. The 
border of the cardiac silhouette was partially effaced by the neighbouring lung changes, but the 
cardiac silhouette was not enlarged. Retrospectively, the CT of the caudal thorax earlier performed 
revealed no abnormalities in the caudal two thirds of the lungs. Tracheal inner diameter measured 
8.92mm and thoracic inlet measurement 6.67cm.  The trachea : thoracic inlet ratio was within 
normal limits for a English Bulldog (0.134) 15,16.
Due to the more severe pulmonary lesions in the perihilar region suggesting the possibility of 
a single dose of furosemide at 2mg/kg was administered 
 atrial 
enlargement was identified and systolic function appeared normal. There were no valvular 
 cardiogenic 
cause of pulmonary oedema was discarded.
The pharynx and the larynx were visually examined using laryngoscope with a light source with 
the animal profoundly sedated. The larynx was found to be grossly inflamed with erythema and 
swelling of the area. No mass, foreign body, laryngeal paralysis or other source of UAO was 
cardiogenic pulmonary oedema, 
intravenously promptly and an echocardiography was performed. Neither left nor right
regurgitations and no evidence of increased filling pressures detected; therefore,
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.identified during examination
DIFFERENTIAL DIAGNOSIS If relevant
From the history, presentation and radiographic findings a non-cardiogenic pulmonary oedema 
was highly suspected. Alternative differential diagnoses included idiopathic interstitial 
pneumonia, neoplastic infiltration or non-witnessed aspiration pneumonia.
A presumptive diagnosis of post-anaesthetic NPPO was made.
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TREATMENT If relevant 
The dog was transferred to the intensive care unit. The patient showed laboured breathing and a 
significant stertor could be heard. Positioning the patient with the neck extended significantly 
improved the level of comfort. A  
MSD 
Animal Health) at 0.2mg/kg/hr was started to provide sedation, analgesia and antitussive therapy 
. Oxygen supplementation via nasal prongs was 
implemented at a flow rate of 1.5L min-1. Saturation of haemoglobin with oxygen was monitored 
using a portable pulse oximeter (Radical 7 Pulse Oximeter; Masimo). No episodes of patient’s 
desaturation were reported, pulse oximeter values were always above 95% of saturation of 
haemoglobin with oxygen.
Salbutamol nebulization therapy (Ventolin: Glaxo Smith Klein) was initiated at a dose of 0.035 
mg/kg TID administered via metered dose inhalers over periods of 6 breaths using an aerosol 
chamber with a fitted face mask (AeroDawg; Truddel Medical International). 
Therapy with dexamethasone (0.2mg/kg IV SID) (Colvasone, Norbook); omeprazole (1mg/kg IV 
BID) (Omeprazole; Star Pharmaceuticals Ltd.); and cefuroxime (20mg/kg IV TID) (Zinacef; 
GlaxoSmithKlein) was initiated due to the possibility of regurgitation followed by aspiration and 
subsequent pneumonia. 
continuous rate infusion of butorphanol  (Dolorex;
with minimal respiratory depression 17,18
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OUTCOME AND FOLLOW-UP  
The animal responded well to treatment. Sixteen hours after the initial clinical signs, the patient 
was bright and alert. Respiratory rate decreased (20 rpm), no cough or increased inspiratory effort 
was detected. All medications were discontinued 36 hours after recognition of the clinical signs. 
The animal was discharged from the hospital 48 hours after this event. Unfortunately, no follow up 
imaging was performed.
Six months after discharge the animal has fully recovered from this episode with no complications 
arising from the NPPO. 
DISCUSSION Include a very brief review of similar published cases 
DIFFERENTIAL DIAGNOSIS
The possibility of aspiration and secondary pneumonia was initially suspected before diagnostic 
imaging was performed.  In anaesthetised dogs, gastric oesophageal reflux (GOR) has a high 
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incidence, which ranges from 16 per cent19 to 55 per cent20. A clinical trial showed a higher 
incidence of GOR (60 per cent vs 40 per cent) when comparing anaesthetised brachycephalic and 
non-brachycephalic dogs, although this was not statistically significant21.  This is, in part, related 
to the high negative intrathoracic pressures generated to overcome the upper respiratory tract 
obstruction 22–24. GOR is associated with an increased risk of aspiration and secondary pneumonia 
22,24.
9
10
11 In this case we excluded the possibility of aspiration pneumonia as the cause of the pulmonary 
12
13 oedema due to the rapid resolution of the clinical signs. Two studies reflected on the duration of 
14
15 hospitalization for dogs with aspiration pneumonia and resolution of clinical signs. Results 
16 showed in these studies ranged from 3 to 5 days of hospitalization in the intensive care unit for 17
18 dogs recovering from aspiration pneumonia 25,26. 
19
20
21 In terms of radiography, there are different radiographic appearances when comparing NPPO to 
22
23 aspiration pneumonia. In aspiration pneumonia the most gravity dependent areas are the most 
24 affected27. The positioning of the patient during aspiration may predict the location of pulmonary 
25
26 infiltrates. In sternal recumbency it is more likely that the right lung is affected, as the right 
27
28 mainstem bronchus is a more direct prolongation of the trachea than the left. In ventrodorsal 
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29 positioning the caudal lung lobes seem to be more affected 28. A recent case series focused on the 
30
31 radiographic appearance of non-cardiogenic pulmonary oedema suggested that a dorsal 
32
33 distribution of the lung lesions seemed to be more often observed in NPPO than in other causes of 
34
35 non-cardiogenic pulmonary oedema, although, the authors could not give an explanation to this 
36 finding5.
37
38
39 In dogs with experimentally induced lung aspiration, radiographic signs were only seen 24 hours 
40
41 post aspiration and clinical signs of cough and respiratory distress were only present two days 
42 28. In this case, clinical signs and radiographic changes occurred between ten to 43 after the 
event 
44 fourteen hours after extubation, although aspiration before sedation cannot be excluded. Also, 
45
46 abnormal radiographic findings were mainly caudodorsally located which differs from cases of 
47
48 aspiration pneumonia.  In human medicine, this post-anaesthetic complication has a variable 
49 onset of clinical signs, it may vary from few minutes to several hours (up to 24 hours) following 
50
51 extubation or relief of obstruction 2,29,30. Delayed onset of laryngeal oedema due to trauma has 
52
53 been reported as a complication of the surgical treatment of BOAS in dogs31. In one case series, 
four dogs developed laryngeal oedema post-surgery. The onset of clinical signs of upper airway 
obstruction, such as increased respiratory effort and cyanosis, were noted one, three, seven and ten 
hours after surgery. The authors mentioned that the laryngeal oedema could have resulted from 
surgery trauma or induced by the ETT31.
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Other causes of non-cardiogenic pulmonary oedema, such as direct lung injury (fire smoke 
exposure, toxin inhalation); neurogenic oedema (electrocution); systemic disease (neoplasia, 
uremic syndrome, pancreatitis); near drowning; blood transfusion; anaphylaxis5 were also 
discarded by clinical history, clinical examination and blood analysis. Neurogenic oedema due to 
seizures is difficult to completely exclude as the animal was not constantly monitored overnight 
and a seizure episode cannot be completely excluded. Although, to date, no history or clinical signs 
of neurologic disease have been reported in this patient, therefore the main causes of neurogenic 
pulmonary oedema were considered unlikely. 
CONTRIBUTION FACTORS FOR THE DEVELOPMENT OF NPPO
PATHOPHYSIOLOGY
It is  
pulmonary 
oedema, due to a suspected upper airway obstruction caused by gross swelling and erythema of the 
larynx. This may have been exacerbated from suspected trauma during tracheal intubation with an 
oversized ETT. A recent study in Beagles suggested that a suitably sized ETT for dogs should 
measure 70% of the internal tracheal diameter measured on thoracic radiography32. In this 
particular case, the measurement using the same method revealed 8.92mm internal tracheal 
diameter which corresponds to a 6.2mm ETT. An 8mm ETT was used to intubate the trachea of 
this patient, which could potentially explain the laryngeal swelling, erythema and secondary post 
extubation UAO.
BOAS
BOAS has an impact on the management of these patients during anaesthesia and recovery 22. 
BOAS is characterised by dynamic and/or static UAO33. These patients are subjected to an 
increased resistance to inspiratory airflow which results in increased inspiratory effort and the 
generation of supraphysiologic negative thoracic and airway pressures 33. In severe cases of BOAS, 
UAO can result in NPPO 22. In our patient brachycephalic conformation may have played a role in 
aggravating the UAO.
SEDATION
This animal was sedated with a low dosage of medetomidine to safely perform the radiographs and 
the echocardiography. In cases of NPPO, α2-agonists must be used with caution. Profound sedation 
with this class of drugs induces recumbency, reduces pharyngeal muscle tone and may predispose 
to hypoventilation. All of these factors can theoretically worsen any UAO already present 22,34. On 
the other hand, sedation may be useful in controlling excessive panting associated with stress, 
reducing further airway swelling or collapse and decreasing oxygen consumption22. This patient 
was closely monitored for signs of UAO including increased stertor/stridor, increased inspiratory 
effort and exaggerated movement of the chest wall.  
believe that the animal described here suffered from type 1 post-
obstructive
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Elevating the patient’s head improved the audible stertor/stridor during sedation. Oxygen was 
supplemented via face mask and haemoglobin saturation with oxygen was monitored via pulse 
oximetry at all times during this process. If necessary antipamezole could have been administrated 
in this case, as this α2-antagonist counteracts the respiratory depression caused by the 
administration of α2-agonists 35,36. Butorphanol can be used to provide sedation, analgesia and 
antitussive therapy with minimal respiratory depression in cases of respiratory distress and was 
used successfully 17,18.
PAEDIATRIC PATIENT
The fact that this was a paediatric patient may have played a role in the development of pulmonary 
oedema in this case. Young animals have a smaller functional residual capacity, therefore they will 
quickly develop hypoxia in the event of an UAO 37,38. The rib cage of young animals is very 
compliant, resulting in less competent ventilation and greater work of breathing. This may 
predispose paediatric patients to hypoxia and ventilatory fatigue, which can be aggravated in the 
event of an UAO38. The larynx of puppies is delicate, and extreme care should be taken to intubate 
the trachea atraumatically 37. This patient was 4 months old and intubation of the trachea was 
performed with an oversized ETT which potentially caused the laryngeal oedema, which was 
theorised to be the cause of the UAO. Hypoxia may have developed quicker in this patient for the 
reasons described above. 
TREATMENT
The priorities in patients presenting NPPO are to relieve the UAO and correct the hypoxaemia. 
Supportive care should be implemented aiming to maintain a patent airway and ensuring adequate 
oxygenation 2,39. Oxygen supplementation, continuous positive airway pressure (CPAP), 
intermittent positive pressure ventilation (IPPV) and positive end-expiratory pressure (PEEP) are 
methods used to fulfil those goals. Other medications such as glucocorticoids and β2-agonists are 
also used to minimize the UAO.
OXYGEN SUPPLEMENTATION
Traditional oxygen therapy is most usually provided via a face mask, nasal prongs or oxygen 
40.  
In a research project including twenty healthy dogs, the mean partial pressure of oxygen (PaO2) in 
arterial samples taken after face mask oxygen supplementation was 371.3 mmHg compared to the 
control group composed by dogs breathing room air (82.43 mmHg) 40. Passive oxygen 
administration via a nasal prongs was chosen in this case to provide oxygen to the patient. 
Unfortunately, no arterial blood gas analysis was performed; this could have provided more reliable 
information regarding the haemoglobin saturation with oxygen and PaO2.
CPAP
CPAP is a mode of ventilation used in spontaneously breathing subjects. This is used in humans 
cage, delivering dry, cold oxygen with FIO2 of 40 to 70% at flow rates of 50 –150 mL/kg/min 
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for the treatment of NPPO and sleep apnoea2,41 . The objective of CPAP is to maintain a positive 
pressure in the airways during inspiration and expiration. This intrathoracic positive pressure at the 
end of expiration will improve alveolar ventilation and re-expand flooded alveoli, promoting the 
fluid to return to the interstitial space 42. Other benefits of CPAP include a reduction in preload due 
to an increase in intrathoracic pressure and a reduction in afterload, via an increase in pericardial 
pressure and reduction in transmural pressure 42. It also improves oxygenation, gas exchange, vital 
signs and reduces work of breathing  43,44. One of the advantages of CPAP delivery is that there is 
no need for tracheal intubation and mechanical ventilation. No CPAP delivering devices have been 
designed for veterinary patients. Two human interfaces for CPAP delivery have been studied in 
dogs, 45,46. In healthy sedated dogs, when comparing CPAP via face mask with traditional oxygen 
therapy delivered via regular face mask, CPAP increased PaO2 by 102 mmHg and was well 
tolerated by the patients 45. Disadvantages have been highlighted in a research project testing three 
methods of non-invasive CPAP delivery (custom-made mask, conical face mask and helmet): 
significant leaks were found when CPAP was delivered to sedated dogs. There is a significant risk 
of rebreathing and hypoxaemia when CPAP was not maintained. The authors concluded that 
animals should always be supervised during administration of CPAP 47. In our patient this method 
of ventilation was not used because it was not available at the time, in our opinion it would have 
been a valid option for treatment of this patient because it would maintain a patent airway, improved 
oxygenation and reduced the work of breathing. Nevertheless, the temperament of the animal could 
have limited the use of CPAP in this case.
IPPV
IPPV with PEEP has been used in veterinary medicine for treatment of non-cardiogenic pulmonary 
oedema 48. The application of PEEP counterbalances the hydrostatic forces leading to pulmonary 
oedema, redistributing the extravascular fluid from the alveoli into perivascular interstitium and 
maintaining airway patency 49. PEEP also improves gas exchange and recruits alveolar units. 
Application of PEEP up to 13 cmH2O improved alveolar gas exchange in experimentally induced 
canine pulmonary oedema 50,51. In this case IPPV and PEEP were not used because this would 
require endotracheal intubation which could have perpetuated the laryngeal inflammation already 
present. In human patients with NPPO, IPPV and PEEP are only implemented in severe cases of 
hypoxaemia, ventilation/perfusion mismatch and poor lung compliance2. IPPV and PEEP may 
present disadvantages when compared to other methods of ventilation such as CPAP. These 
included: an increased risk of morbidity and mortality;  the development of pneumonia, volutrauma 
and barotrauma; requirements for expensive and specialised equipment and staff; higher costs of 
patient management in an ICU setting 45,52.
FUROSEMIDE
In patients suffering from fluid overload, diuretics may play a part in the resolution of pulmonary 
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oedema, but in other cases their role remains uncertain 53,54. The reasoning behind using diuretics 
in these cases is to attempt to decrease the intravascular volume and alter Starling’s equation in 
favour of intra capillary filtration and oedema resolution 30. Furosemide was administered after 
radiographs confirmed pulmonary oedema. We had a concern that our patient may have been fluid 
overloaded, as she received fluid therapy at a rate of 4ml/kg/hr for a period of fifteen hours. The 
echocardiography discarded that possibility as well as cardiogenic pulmonary oedema. 
Therefore the use of furosemide could have been avoided in this particular case.
CORTICOSTEROIDS
Upper airway inflammation is associated with airway narrowing and obstruction. This increases 
airway resistance, may perpetuate inflammation and worsen coughing episodes. In the short term 
glucocorticoids may be useful in animals with BOAS with pharyngeal or laryngeal swelling55. 
Glucocorticoids were used in this case after examination of the larynx, to decrease the inflammation 
detected in that area.
SALBUTAMOL
β2-agonists may be useful in lower airway disease in dogs55. In human medicine, aerosolized 
salbutamol was found to accelerate the resolution of pulmonary oedema, improve blood 
oxygenation, and stimulate cardiovascular function after lung lobe resection56.  β2-agonists could 
potentially increase the rate of alveolar fluid clearance through increased active cation transport, 
which may well accelerate the resolution of the clinical signs of pulmonary oedema57,58. The use of 
β2-agonists is current practice in the treatment of NPPO in human medicine59. Interstitial oedema 
may induce narrowing of the bronchial lumen. This can be detected on thoracic auscultation as 
wheezing sounds57. In our case, clear wheezing was detected on thoracic auscultation; therefore, 
nebulisation with salbutamol was initiated.
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field
• Endotracheal intubation should be performed atraumatically with an appropriately sized ETT (in 
length and diameter). When intubating the trachea of a patient correct position of the patient, use of 
laryngoscope (which provides adequate light and visualization of the larynx) and 
appropriate depth of anaesthesia are extremely important to avoid complications.
• Delayed onset of laryngeal oedema resulting in NPPO is possible; therefore animals should be 
closely monitored in the post-operative period.
• NPPO is a potential complication in the pre-anaesthetic period and can be treated with oxygen 
supplementation, corticosteroids and short-acting β2-agonists. 
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 Early recognition of the clinical signs and establishment of a prompt diagnosis is extremely 
important in the outcome of the case.
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